Company Filing History:
2 out of 48 
1 out of 1,168 
1 out of 1 
Years Active: 2012-2019
Title: Naftali Stern: Innovator in Enzyme Replacement Therapy
Introduction
Naftali Stern is a prominent inventor based in Nir Zvi, Israel. He has made significant contributions to the field of enzyme replacement therapy, particularly in the treatment of lysosomal storage diseases. With a total of 4 patents to his name, Stern's work has the potential to impact many lives.
Latest Patents
One of his latest patents focuses on enzyme replacement therapy for treating lysosomal storage diseases. This invention relates to chimeric proteins, including protein hormone-therapeutic protein conjugates and fusion proteins. The protein hormone selected is capable of crossing the blood-brain barrier, which is crucial for effective treatment. Another notable patent involves adipocyte-specific constructs and methods for inhibiting platelet-type 12 lipoxygenase expression. This invention provides constructs that modulate platelet-type 12 lipoxygenase in adipose tissue, offering potential solutions for conditions associated with excess fat cell mass and obesity.
Career Highlights
Throughout his career, Naftali Stern has worked with reputable organizations such as the Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center and Yeda Research and Development Company. His innovative approaches have garnered attention in the scientific community.
Collaborations
Stern has collaborated with notable individuals in his field, including Gary Weisinger and Rona Limor. These partnerships have likely contributed to the advancement of his research and inventions.
Conclusion
Naftali Stern's contributions to enzyme replacement therapy and his innovative patents highlight his role as a significant inventor in the medical field. His work continues to pave the way for advancements in treatment options for lysosomal storage diseases and obesity-related conditions.